Ibuprofen Vitenda (Ibuprofen)

Ibuprofen blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, it reduces pain signaling, fever generation, and the inflammatory response in affected tissues.

The appropriate dose of Ibuprofen Vitenda is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Dosage instructions should always follow the prescriber’s recommendation and the product labeling.

Safety of ibuprofen during pregnancy or lactation depends on the trimester and individual risk factors. Generally, ibuprofen is avoided in the third trimester and used with caution earlier. Breastfeeding mothers should consult their physician, as ibuprofen can be excreted in milk in small amounts.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibuprofen Vitenda shares the core mechanism of COX inhibition with other NSAIDs such as naproxen or diclofenac. Compared with some alternatives, ibuprofen has a relatively short half‑life, which may allow flexible dosing but also requires consistent administration to maintain effect. Safety profiles are similar, with gastrointestinal and renal considerations common to the class.

Ibuprofen Vitenda should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, heat, and direct sunlight to maintain potency and stability throughout its shelf life.

Ibuprofen Vitenda is taken orally, usually with a full glass of water. It may be taken with or without food, although taking it with meals can reduce gastrointestinal discomfort. Patients should follow the prescriber’s instructions regarding timing and frequency.

The most serious risks include gastrointestinal bleeding or ulcer perforation, severe allergic reactions such as anaphylaxis, acute kidney injury, and increased cardiovascular events like heart attack or stroke, especially with high‑dose or prolonged use. Prompt medical attention is required if any of these occur.

Individuals with a known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcers, severe renal or hepatic impairment, uncontrolled hypertension, or a history of cardiovascular disease should avoid Ibuprofen Vitenda unless specifically directed by a healthcare professional.